News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
News Anthropic joins Gates Foundation on $200m health AI pledge Anthropic and the Gates Foundation's initiative will close a gap in access to AI tools between high- and lower-income countries.
News Clock starts ticking on UK's single patient record plan In today's King's Speech, the UK government unveiled the NHS Modernisation Bill, starting the process of introducing a single patient record.
News Isomorphic raises $1.2bn for AI drug hunt Isomorphic Labs has added to the lustre attached to its AI-powered drug discovery engine by raising an eye-watering $1.2 billion in a Series B round.
News Boehringer, Brainomix plan new trial of lung fibrosis AI Boehringer and Brainomix are planning a prospective trial of an AI to diagnose pulmonary fibrosis, after positive results in an observational study.
News Cellular Intelligence scoops up Novo's Parkinson's therapy Novo Nordisk has sold the rights to one of the flagship candidates in its now-defunct cell therapy unit to AI start-up Cellular Intelligence.
Oncology ASCO 2026: All about DNA damage response, with Luke Piggot Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
